Literature DB >> 24161745

Total glucosides of paeony inhibit the proliferation of fibroblast-like synoviocytes through the regulation of G proteins in rats with collagen-induced arthritis.

Xiao-Yi Jia1, Yan Chang2, Xiao-Jing Sun3, Hua-Xun Wu4, Chun Wang3, Hong-Mei Xu3, Lei Zhang3, Ling-Ling Zhang3, Yong-Qiu Zheng3, Li-Hua Song5, Wei Wei6.   

Abstract

The aim of this study was to investigate the expression of G proteins in fibroblast-like synoviocytes (FLSs) from rats with collagen-induced arthritis (CIA) and to determine the effect of total glucosides of paeony (TGP). CIA rats were induced with chicken type II collagen (CCII) in Freund's complete adjuvant. The rats with experimental arthritis were randomly separated into five groups and then treated with TGP (25, 50, and 100mg/kg) from days 14 to 35 after immunization. The secondary inflammatory reactions were evaluated through the polyarthritis index and histopathological changes. The level of cyclic adenosine monophosphate (cAMP) was measured by radioimmunoassay. The FLS proliferation response was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The toxin-catalyzed ADP-ribosylation of G proteins was performed through autoradiography. The results show that TGP (25, 50, and 100mg/kg) significantly decreased the arthritis scores of CIA rats and improved the histopathological changes. TGP inhibited the proliferation of FLSs and increased the level of cAMP. Moreover, the FLS proliferation and the level of Gαi expression were significantly increased, but the level of Gαs expression was decreased after stimulation with IL-1β (10ng/ml) in vitro. TGP (12.5 and 62.5μg/ml) significantly inhibited the FLS proliferation and regulated the balance between Gαi and Gαs. These results demonstrate that TGP may exert its anti-inflammatory effects through the suppression of FLS proliferation, which may be associated with its ability to regulate the balance of G proteins. Thus, TGP may have potential as a therapeutic agent for the treatment of rheumatoid arthritis.
© 2013.

Entities:  

Keywords:  Fibroblast-like synoviocytes; G protein; IL-1β; Proliferation; Total glucosides of paeony

Mesh:

Substances:

Year:  2013        PMID: 24161745     DOI: 10.1016/j.intimp.2013.09.007

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  14 in total

1.  Total glucosides of paeony inhibits liver fibrosis and inflammatory response associated with cirrhosis via the FLI1/NLRP3 axis.

Authors:  Jie Zhang; Yiwei Fu; Bin Yang; Xiaoxing Xiang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Paeoniflorin ameliorates collagen-induced arthritis via suppressing nuclear factor-κB signalling pathway in osteoclast differentiation.

Authors:  Haiyan Xu; Li Cai; Lili Zhang; Guojue Wang; Rongli Xie; Yongshuai Jiang; Yuanyang Yuan; Hong Nie
Journal:  Immunology       Date:  2018-02-17       Impact factor: 7.397

3.  A rare case of juvenile localised scleroderma with intra-oral and dental involvement.

Authors:  Peng Wang; Wei Guo; Shutai Liu
Journal:  Exp Ther Med       Date:  2015-10-12       Impact factor: 2.447

4.  Anti-arthritic Effects of Total Flavonoids from Juniperus sabina on Complete Freund's Adjuvant Induced Arthritis in Rats.

Authors:  Jun Zhao; Tao Liu; Fang Xu; Shuping You; Fang Xu; Chenyang Li; Zhengyi Gu
Journal:  Pharmacogn Mag       Date:  2016 Jul-Sep       Impact factor: 1.085

5.  CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents.

Authors:  Feng Zhang; Jin-Ling Shu; Ying Li; Yu-Jing Wu; Xian-Zheng Zhang; Le Han; Xiao-Yu Tang; Chen Wang; Qing-Tong Wang; Jing-Yu Chen; Yan Chang; Hua-Xun Wu; Ling-Ling Zhang; Wei Wei
Journal:  Front Pharmacol       Date:  2017-12-22       Impact factor: 5.810

Review 6.  A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis.

Authors:  Zhi-Tao Feng; Juan Xu; Guo-Chao He; San-Jin Cai; Juan Li; Zhi-Gang Mei
Journal:  Clin Rheumatol       Date:  2017-07-27       Impact factor: 2.980

7.  Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in Rheumatoid Arthritis Using Network Pharmacology and Molecular Docking.

Authors:  Liang Liang Bai; Hao Chen; Peng Zhou; Jun Yu
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

8.  Guizhi-Shaoyao-Zhimu decoction attenuates bone erosion in rats that have collagen-induced arthritis via modulating NF-κB signalling to suppress osteoclastogenesis.

Authors:  Shu-Jun Wei; Qing Zhang; Yong-Jing Xiang; Lan-Yu Peng; Wei Peng; Qiang Ren; Yong-Xiang Gao
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

9.  CP-25, a novel compound, protects against autoimmune arthritis by modulating immune mediators of inflammation and bone damage.

Authors:  Yan Chang; Xiaoyi Jia; Fang Wei; Chun Wang; Xiaojing Sun; Shu Xu; Xuezhi Yang; Yingjie Zhao; Jingyu Chen; Huaxun Wu; Lingling Zhang; Wei Wei
Journal:  Sci Rep       Date:  2016-05-17       Impact factor: 4.379

10.  A Modified Compound From Paeoniflorin, CP-25, Suppressed Immune Responses and Synovium Inflammation in Collagen-Induced Arthritis Mice.

Authors:  Jingyu Chen; Ying Wang; Huaxun Wu; Shangxue Yan; Yan Chang; Wei Wei
Journal:  Front Pharmacol       Date:  2018-06-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.